abbvie contract manufacturing annual report

2.1.1 Why Do Firms Outsource Manufacturing? The aim of this Maternal Immunization book is to provide a contemporary overview of vaccines used in pregnancy (and the lactation period), with emphasis on aspects of importance for the target groups, namely, rationale for the use of ... The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. Key highlights of the Lipid Contract Manufacturing market report: Estimated compound annual growth rate of the market and sub-markets. Laboratory Corporation Of America Holdings. Report Overview. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________, https://www.reportlinker.com/p06086875/?utm_source=GNW. This book begins by highlighting the anatomical, physiological and developmental differences between adults and children of different ages. Discover the key drivers and challenges affecting the market. (920) 467-4621. The global market for contract pharmaceutical research services should grow from $67.1 billion in 2021 to $89.8 billion by 2026, at a CAGR of 6.0% during the forecast period of 2021-2026. - Evaluate stability trends and prepare reports. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. 2.3 Driving and Restrictive Forces for Pharmaceutical Contract Manufacturing 2.3.1 Pharmaceutical Contract Manufacturing: Market Drivers 2.3.2 Pharmaceutical Contract Manufacturing: Market Restraints, 3. The Manufacturing sector comprises establishments engaged in the mechanical, physical, or chemical transformation of materials, substances, or components into new products. The gastrointestinal (GI) therapeutics industry is on the rise; growing to reach $68,237.0m by 2028. In this brand new 265-page report you will receive 154 tables and 50 figures– all unavailable elsewhere. • Aesica Pharmaceuticals. Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6, Do you have any custom requirements we can help you with? If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987, American Association of Colleges of Pharmacy American College of Clinical Pharmacy American Pharmacists Association American Society for Pharmacy Law American Society of Consultant Pharmacists American Society of Health-System Pharmacists Association of Special Pharmaceutical Manufacturers Australian College of Pharmacy Biotechnology Industry Organization Canadian Pharmacists Association Canadian Society of Hospital Pharmacists Chinese Pharmaceutical Association College of Psychiatric and Neurologic Pharmacists Danish Association of Pharmaconomists European Association of Employed Community Pharmacists in Europe European Medicines Agency Federal Drugs Agency General Medical Council Head of Medicines Agency International Federation of Pharmaceutical Manufacturers & Associations International Pharmaceutical Federation International Pharmaceutical Students’ Federation Medicines and Healthcare Products Regulatory Agency National Pharmacy Association Norwegian Pharmacy Association Ontario Pharmacists Association Pakistan Pharmacists Association Pharmaceutical Association of Mauritius Pharmaceutical Group of the European Union Pharmaceutical Society of Australia Pharmaceutical Society of Ireland Pharmaceutical Society Of New Zealand Pharmaceutical Society of Northern Ireland Professional Compounding Centers of America Royal Pharmaceutical Society The American Association of Pharmaceutical Scientists The BioIndustry Association The Controlled Release Society The European Federation of Pharmaceutical Industries and Associations The European Personalised Medicine Association The Institute of Clinical Research The International Society for Pharmaceutical Engineering The Pharmaceutical Association of Israel The Pharmaceutical Research and Manufacturers of America The Pharmacy Guild of Australia The Society of Hospital Pharmacists of Australia, Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/. - Stability room management as per the relevant procedure. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. DUBLIN--(BUSINESS WIRE)--The "Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging 2021-2026" report has been added to ResearchAndMarkets.com's offering.. • What are the strengths and weaknesses for the leading pharmaceutical CMOs? Details Table 3.60 Dr. Reddy’s Laboratories Cumulative Drug Master File (DMF) Applications: Applications Accepted by Region, Regional Share (%), 2017 Table 3.61 Dr. Reddy’s Laboratories Contract Manufacturing: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2015-2019 Table 3.62 Dr. Reddy’s Laboratories: Contract Manufacturing Revenue ($m) by Regional Market and Revenue Share (%), FY 2019 Table 3.63 Dr. Reddy’s Laboratories: SWOT Analysis Table 3.64 DPT Laboratories Ltd. New York, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical Contract Manufacturing Market Research Report by Type of Contract 3.32 Huapont Pharmaceutical Co., Ltd. 3.32.1 China Pharmaceutical Trade 3.33 Lonza 3.33.1 Lonza Is a Leader in Biologics Manufacturing 3.33.2 Lonza Contract Manufacturing and Development 3.33.3 Investing in Advanced Biological Drug Sectors 3.33.4 The Promise of Antibody-Drug Conjugates (ADCs) 3.33.5 The Regenerative Medicine Future in Japan 3.33.6 Lonza: SWOT Analysis 3.34 Nipro Corporation: Japan’s Leading CMO 3.34.1 Nipro Pharmaceutical Contract Manufacturing Capabilities 3.34.2 Nipro Revenues 2014-2019 3.34.3 Biosimilars and Anti-Cancer Drugs Are Opportunities for Future Growth: SWOT Analysis 3.35 Paragon Bioservices, Inc. 3.35.1 Paragon Announced Expansion of its New Manufacturing Facility 3.36 Patheon – One of the Top 3 CMOs 3.36.1 Patheon – Global leader in Pharmaceutical Development Services 3.36.2 Contract Manufacturing Services at Patheon 3.36.3 Steady Revenue Growth 2012-2017 3.36.4 DPx Holdings: Developments 3.36.5 Adding New Formulations and Formulation Development Services 3.36.6 Expanding Services Through Acquisition, 2016 3.36.7 Patheon: SWOT Analysis 3.37 Recipharm 3.37.1 Contract Development and Manufacturing Services 3.37.2 Recipharm: Financial Performance 2013-2018 3.37.3 Recipharm Invests in Facility Expansion 3.37.4 Recipharm Growing in the Development and Technology Market Through Acquisitions 3.37.5 Recipharm: SWOT Analysis 3.38 F. Hoffman-La Roche Ltd. 3.38.1 Amplified Revenue Growth in Pharma Manufacturing 2012-2017 3.38.2 Value of Innovation 3.38.3 Approvals and Extensions in Pharmaceuticals Division 3.38.4 Launch of New Products Drive the Growth of the Company 3.39 Royal DSM 3.39.1 Amplified Revenue Growth in Pharma Manufacturing 2013-2018 3.39.2 DSM Pharmaceuticals Products/DPx Holdings: Manufacturing Services 3.39.3 DSM Sinochem Pharmaceuticals: A World Leader in Antibacterial Manufacturing 3.39.4 DPx Holdings: A New Pharma Leader 3.39.5 Investing in Biopharma Manufacturing 3.39.6 Expanding API Manufacturing 3.39.7 Generics and Biologics Offer Room for Growth 3.40 Shandong Xinhua Pharmaceutical 3.40.1 Experience in APIs and Finished Dosage Forms 3.40.2 Shandong Xinhua: Strong Revenue Growth 2013-2018 3.40.3 Growing through Joint Ventures 3.40.4 Looking to Expand in the US and EU 3.41 Siegfried 3.41.1 Siegfried’s Acquisitions, 2013-2019 3.41.2 Expanding Siegfried’s Manufacturing Footprint Globally 3.41.3 Expanding High Potency API Capabilities 3.41.4 Siegfried: Financial Performance 2013-2018 3.41.5 Siegfried’s Characteristics within the Contract Manufacturing Market: SWOT Analysis 3.42 TEVA Pharmaceutical, Ltd. 3.42.1 API Manufacturing Services 3.42.2 Teva API: Financial Performance 2012-2017 3.42.3 Building a Footprint in Mexico, India and China 3.42.4 Teva API: SWOT Analysis 3.43 Therapure Biopharma, Inc. 3.43.1 Therapure Collaborated with 3SBio Inc., and CPE Funds 3.44 UPM Pharmaceuticals 3.45 Vetter Pharmaceutical 3.45.1 Vetter is an Injectable Manufacturing Specialist 3.45.2 Services, Collaborations and Differentiating Factors 3.45.3 Expanding Services in the US and Asia 3.45.4 Biologics: Opportunity for Growth for Vetter 3.46 Xcelience, LLC (Acquired by Capsugel) 3.47 Samsung Biologics Inc. 3.47.1 Samsung Biologics, The Growth Factor 3.47.2 Samsung Biologics, Financial Overview 3.47.3. Which technologies will prevail and who are the leading companies succeeding in these sectors and why? • What strategies have CMOs been implementing for sales growth in recent years? Table 19.1. September 07, 2021 06:25 ET Outsourcing that has been transformed from "pay for services" to "partnerships and collaborations" is considered the most successful strategy to bring innovation into the drug industry. Automation is a rising trend in the supply chain as a way to reduce time to market and enhance efficiency. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets3. Jobs View All Jobs Our 317-page report provides 185 tables, 110 figures and analysis of 30 leading companies. Any need for specific country, geo region, market segment or specific company information? If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports. However, there is still a role to be played by specialist CMOs, particularly those that offer biological drug manufacturing services. Pharmaceutical Contract Manufacturing Market Research Report by Type of Contract Manufacturing (API or Bulk Drug Manufacturing and Final Dosage Form), by Service (Biologics Manufacturing Services, Drug Development Services, and Pharmaceutical Manufacturing Services), by End-user, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact . The global market for contract pharmaceutical manufacturing, research and packaging services is forecast to grow from $168 billion in 2021 to $214.7 billion by 2026, at a compound annual growth . Major traders, distributors, and vendors. Waco, TX. We OFFER that. Leading Contract Manufacturing Organisations 3.1 Alcami Corporation – A Contract Development and Manufacturing Organization 3.1.1 Alcami: Manufacturing Services and Capabilities 3.1.2 Divisional Segmentation – Breakdown of Alcami’s Service 3.1.3 Alcami Focuses on Advancing its Analytical Testing Turnaround Time 3.1.4 Alcami Extended its Laboratory Service Program 3.1.5 Alcami: Madison Dearborn Partners 3.1.6 Alcami Expands its Sales Office 3.1.7 Alcami Partnered with Solasia Pharma for Manufacturing Active Pharmaceutical Ingredient 3.2 AbbVie Contract Manufacturing 3.2.1 AbbVie Offers Full-Service Contract Manufacturing 3.2.2 Expanding and Adding New Services: 2018-2019 3.2.3 Biologics and HPAPIs Are Opportunities for Growth 3.3 Aenova Group 3.3.1 Acquisition of Haupt Creates European CMO Giant 3.3.2 Aenova’s Ever Expanding Manufacturing Capacity 3.3.3 Aenova’s Competitive Position in the Contract Manufacturing Market: SWOT Analysis 3.3.4 Aenova: New Manufacturing Facilities to Expand Geographic Presence 3.4 Aesica Pharmaceuticals 3.4.1 Aesica Manufactures APIs and Finished Dosage Forms 3.4.2 Acquisitions Drive Revenue Growth 3.4.3 Partnering with Academia for Innovative Solutions 3.4.4 Growth through Acquisitions and Internal Expansion 3.4.5 Aesica: Opportunities for Expansion 3.5 Ajinomoto Althea, Inc. 3.5.1 Ajinomoto Althea Expands its Manufacturing Capabilities 3.5.2 Ajinomoto: New U.S. Patent for Manufacturing Crystal Monoclonal Antibodies 3.5.3 Ajinomoto Althea Expanding its Manufacturing Capacity 3.6 Albany Molecular Research, Inc. 3.6.1 Acquiring New Businesses to Expand Capabilities and Services 3.6.2 Expanding Business Operations in New Geographies 3.6.3 Collaborations to Enhance Services 3.6.4 AMRI Acquisition of Euticals S.p.a 3.7 Alkermes 3.7.1 Collaboration as a Growth Strategy to Develop and Commercialize Products 3.7.2 Alkermes: Clinical Development Program 3.8 Almac Group 3.8.1 Almac’s Manufacturing Services 3.8.2 Almac Adding Capacity Globally 3.8.3 New Services Added 3.8.4 Almac Group: Contract Manufacturing Market Outlook 3.9 Amatsigroup (Eurofin Amtasigroup) 3.9.1 Amatsi: Contract Manufacturing Agreement 3.9.2 Mergers and Acquisitions to Enhance Market Presence 3.9.3 Amatsigroup Expands its Operations and Product Portfolio 3.10 Aurobindo Pharma 3.10.1 API Manufacturing Services 3.10.2 Aurobindo Pharma: Steady Revenue Growth 2012-2017 3.10.3 Aurobindo Expanding Outside of Antibacterial 3.10.4 Aurobindo: Opportunities for Expansion 3.11 Avid Bioservices, Inc. 3.11.1 Avid Focuses on Expanding its Manufacturing Capacity 3.11.2 Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture 3.11.3 Avid Bioservices Expands Process Development Capabilities and Laboratory Infrastructure 3.12 Bayer Healthcare AG 3.12.1 Bayer Focuses on Providing Superior Pharmaceutical Services 3.12.2 Bayer Focuses Quality for all the Products and Services Offered by the Company 3.12.3 Bayer Pharmaceuticals main focus areas 3.12.4 Bayer’s Vision 2020 3.13 Baxter BioPharma Solutions 3.13.1 BioPharma Solutions Offers a Broad Product Portfolio of Sterile Contract Manufacturing Services and Solutions 3.13.2 BioPharma Focuses on Expanding its Manufacturing Capacities 3.13.3 Baxter BioPharma Solutions and SAFC Collaborate on Complete ADC Offering 3.13.4 Baxter BioPharma Solutions Focuses on Research & Development Investments 3.13.5 Baxter BioPharma is the Global Leader in Sterile Fill and Finish 3.13.6 Baxter BioPharma SWOT Analysis 3.14 Biomay AG 3.14.1 Biomay Offers Fully Integrated GMP Capacities 3.14.2 Biomay Focuses on Increasing its Capital 3.15 Boehringer Ingelheim Contract Manufacturing 3.15.1 BI Existing Units and Expansion to new areas 3.15.2 Production Through to Fill and Finished Biopharmaceuticals 3.15.3 A Track Record of Production for 29 Biopharma Products 3.15.4 Increasing Revenue from Contract Manufacturing, 2012-2019 3.15.5 Pulling Out of Small Molecule API Manufacturing 3.15.6 Expanding through New Services 3.15.7 Boehringer Ingelheim Biopharmaceuticals: Opportunities for Growth 3.16 Catalent Pharma Solutions - the World’s Leading CMO 3.16.1 Catalent: Manufacturing Services and Capabilities 3.16.2 Divisional Segmentation – Catalent’s Service 3.16.3 Catalent Pharma’s Revenue Growth, 2014-2019 3.16.4 Catalent Is Expanding its Softgel Technologies Division 3.16.5 Quadrupling Biopharmaceutical Manufacturing Capacity 3.16.6 Expansion of Packaging Services in Asia-Pacific and Europe: 2018 3.16.7 Adding New Early-Stage Development Services 3.16.8 Expansion in Japan – Growth Prospects for Catalent 3.16.9 New Business Contracts 2014-2019 3.16.10 Catalent: Opportunities for Growth 3.17 Charles River Laboratories International, Inc. 3.17.1 Charles River Laboratories Focuses on Increasing the Service Areas of its Offerings 3.17.2 Strategic Acquisitions as a Growth Strategy to Expand Product Portfolio 3.17.3 Charles River Laboratories Revenue Growth, 2013-2018 3.18 Cardinal Health, Inc. 3.18.1 Cardinal Health Focuses on Helping Healthcare Organizations for Patient Safety 3.18.2 Cardinal Revenue Growth, 2013-2018 3.19 CordenPharma International 3.19.1 CordenPharma Service Division 3.19.2 CordenPharma Emerging in the API Market 3.19.3 Investments in Highly Potent Capabilities 3.19.4 CordenPharma: SWOT Analysis 3.20 Daito Pharmaceutical Co., Ltd. 3.20.1 Daito Has a Portfolio of More than 43 APIs 3.20.2 Rapid Growth in Revenue and Operational Profit: Daito Financial Performance 2013-2018 3.20.3 Daito Is Well-Placed for Asian Market Growth – SWOT Analysis 3.21 Delpharm 3.21.1 Finished Dosage Form Manufacturing for Developed Markets 3.21.2 Delpharm: Rapid Revenue Growth Via Acquisitions, 2013-2019 3.21.3 Delpharm: Outlook and Prospects for Growth 3.22 Divis Laboratories 3.22.1 Divis Laboratories and the Contract Manufacturing Industry 3.22.2 Divis Laboratories: A Rapidly Growing CMO, 2014-2019 3.22.3 Divis Laboratories: API Manufacturing 3.23 Dr. Reddy’s Laboratories Ltd. 3.23.1 API and FDF Manufacturing Services 3.23.2 Dr. Reddy’s PSAI: Strong Revenue Growth 2012-2017 3.23.3 Advancing in Complex Drug Manufacturing 3.23.4 Expanding in the European Manufacturing Market 3.24 DPT Laboratories, Ltd. 3.24.1 Mylan Acquires Topicals-Focused Specialty and Generic Business of DPT 3.24.2 DPT Enhances Flexibility and Efficiencies 3.24.3 DPT Enhances Capabilities with New High-Speed Filling Center 3.25 Esteve Qu`mica 3.25.1 Esteve Química Manufactures APIs for Developed and Emerging Markets 3.25.2 Expanding in the US, 2018 3.25.3 Esteve Química: SWOT Analysis 3.26 Evonik Degussa 3.26.1 Investing in API and Drug Delivery Services 3.26.2 Moderate Growth in Pharmaceutical Manufacturing Services, 2013-2018 3.26.3 Evonik Is a HPAPI Specialist 3.26.4 Evonik Continues to Grow Across All Segments 3.26.5 How Can Evonik Expand in the Pharmaceutical Contract Manufacturing Market? The Fly team scours all sources of company news, from mainstream to cutting edge,then filters out the noise to deliver shortform stories consisting of only market moving content. Would you like a free report overview of the report of your choice? | Source: New approaches that have transformed classical aseptic production methods are appearing almost daily. This book reviews emerging technologies Visiongain’s study is intended for anyone requiring commercial analyses for pharmaceutical contract manufacturing market. Phone: +44 (0) 20 7549 9987 | Email: contactus@visiongain.com, Airport House, Purley Way, Surrey, London, CR0 0XZ United Kingdom, Copyright © 2021 Visiongain. Found insideKey Features: 800 signed articles, authored by prominent scholars, are arranged A-to-Z and published in a choice of electronic or print formats Although arranged A-to-Z, a Reader's Guide in the front matter groups articles by thematic areas ... Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn. • Profiles of the 55 leading pharmaceutical CMOs which include: • AbbVie Contract Manufacturing. Ltd., Labcorp India Pvt. Profiles of the 50 leading pharmaceutical contract manufacturing organizations: AbbVie Contract Manufacturing. - Evaluate stability trends and prepare reports. Phone. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. Ajinomoto Althea, Inc. Albany Molecular Research, Inc. Alkermes plc. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Report Scope. Details Table 3.14 Albany Molecular Research, Inc. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing Market?4. Almac Group. 4.2 Strategies for Growth: Prospects for Leading CMOs 4.3 High Demand for Biopharmaceutical Manufacturing Services 4.4 Investing in Novel Technologies 4.5 Outlook for API Manufacturers, Appendices Some Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Visiongain Report Evaluation Form, List of Tables Table 2.1 Benefits and Drawbacks to Outsourcing Pharmaceutical Manufacturing, 2020 Table 2.2 Contract Manufacturing Market Total Revenue: Total Revenue ($bn), Annual Growth (%), 2016-2018 Table 2.3 Contract Manufacturing Market by Leading Country: Market Size ($bn), Market Share (%), 2018 Table 3.1 Alcami Details Table 3.2 Alcami Facility Details Table 3.3 AbbVie Contract Manufacturing: Details Table 3.4 AbbVie Contract Manufacturing Facility Capabilities Table 3.5 AbbVie Contract Manufacturing SWOT Analysis Table 3.6 Aenova Group Details Table 3.7 Aenova Group Manufacturing Capacity by Dosage Form Table 3.8 Aenova Group Manufacturing Facility Details Table 3.9 Aenova Group SWOT Analysis Table 3.10 Aesica Details Table 3.11 Aesica Pharmaceuticals: Revenue ($m), Operating Profit ($m), Operating Margin (%), Annual Growth Rates (%), CAGRs (%), 2014-2019 Table 3.12 Aesica SWOT Analysis Table 3.13 Ajinomoto Althea, Inc. They also pursued mergers and acquisitions, as well as joint venture strategies, to get access to other markets. Contract manufacturing represents the largest sector of the pharma outsourcing industry. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. What are the dynamic growth sectors? The global market for contract pharmaceutical manufacturing, research and packaging services is forecast to grow from $168 billion in 2021 to $214.7 billion by 2026, at a compound annual growth . This updated study discusses market-leading companies worldwide, as well as the strategies they have employed to develop in recent years. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Contract Manufacturing Market?Read the full report: https://www.reportlinker.com/p06086875/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Company Description. Automation is appealing for a variety of reasons, the most important of which is that it reduces human contact and hence interference. DUBLIN--(BUSINESS WIRE)--The "Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging 2021-2026" report has been added to ResearchAndMarkets.com's offering.. Found insideTo explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly ... The Biologics Manufacturing Services is further studied across Biologics API Manufacturing and Biologics FDF Manufacturing. Details Table 3.42 Cardinal Health Financial Performance: Revenue ($b), Annual Growth Rates (%), CAGR (%), 2013-2018 Table 3.43 CordenPharma International Details Table 3.44 CordenPharma Facilities and Service Details Table 3.45 CordenPharma SWOT Analysis Table 3.46 Daito Pharmaceutical: Details Table 3.47 Daito Pharmaceuticals Financial Performance: Revenue ($m), Revenue (Â¥m), CAGR (%), 2013-2018 Table 3.48 Daito Pharmaceuticals SWOT Analysis Table 3.49 Delpharm Details Table 3.50 Delpharm: Facilities and Services Table 3.51 Delpharm: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2014-2018 Table 3.52 Delpharm: SWOT Analysis Table 3.53 Divis Laboratories Details Table 3.54 Divis Laboratories: Facility Details, Production Capacity and Services Table 3.55 Divis Laboratories: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2013-2018 Table 3.56 Divis Laboratories Revenue Distribution: Revenue ($m), Share of Total (%), 2018 Table 3.57 Divis Laboratories Revenue by Region: Revenue ($m), Share of Total (%), 2018 Table 3.58 Divis Laboratories Contract Manufacturing: SWOT Analysis Table 3.59 Dr. Reddy’s Laboratories Ltd. Details Table 3.40 Charles River Financial Performance: Revenue ($m), Annual Growth Rates (%), CAGR (%), 2013-2018 Table 3.41 Cardinal Health, Inc. - Writing the annual stability assessment reports. Pharmaceutical companies squeezed by healthcare providers and governments on pricing and patent cliff approached contract manufacturing organizations to maintain their positions in this highly competitive environment. AbbVie hiring Manufacturing Operator III in Waco, Texas . Job Description Linkedin.com . Based on Service, the Pharmaceutical Contract Manufacturing Market was studied across Biologics Manufacturing Services, Drug Development Services, and Pharmaceutical Manufacturing Services. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. The Global Pharmaceutical Contract Development & Manufacturing Market size was estimated at USD 99.44 Billion in 2020 and expected to reach USD 107.61 Billion in 2021, at a Compound Annual Growth . Continuous investments made by the pharmaceutical and outsourcing firms to expand their manufacturing facilities have positively impacted . powered by Quick SEO Help. from 8 AM - 9 PM ET. Report this job. Pharmaceutical companies have sought to take advantage of the benefits of contract manufacturing – lower costs, increased flexibility and external expertise – to focus resources on core competencies in drug development and marketing. With more than 300 service listings and hundreds of contract service providers, Contract Pharma's Contract Services Directory is the premier go-to resource for outsourcing and contract services. Sign up today for your free Reader Account. Immune Pharmaceuticals Immunomedics Index Ventures Indoco Remedies Intellect Neurosciences International Chemical Investors Group (ICIG) IRIX Pharmaceuticals Janssen JK Pharmaceutical JLL Partners Johnson & Johnson (J&J) KWS BioTest Limited Laboratoire Aguettant Laboratoires Besins Lanxess Corporation Lonza Group Ltd. Lusomedicamenta Madison Dearborn Partners, LLC (MDP) Marine Ingredients Marinopoulos Group Merck KGaA Mesoblast Micron Technologies Molecular Partners Mundipharma Mylan New York Center for Nanomedicine Research (NYCNMR) NIH CRM Nikon Nipro Corporation Novozymes Octane OncoMed Pharmaceuticals OPKO Health. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. AbbVie price target lowered to $142 from $148 at SVB Leerink 09/01/21 Mizuho FDA JAK safety update not great 'but AbbVie selloff overdone, says Mizuho 09/01/21 SVB Leerink AbbVie's Rinvoq should 'still hit' $7-$8B in peak sales, says SVB Leerink 09/01/21 JPMorgan AbbVie move on Rinvoq FDA safety update looks 'overdone,' says JPMorgan Offers an idea of its revenue generation and customer base compared to others data with LIMs! • Profiles of the research and development productivity is increasing in the Global Contract! From 2014, home, or mills and characteristically use power-driven machines and materials-handling equipment ability to prevent manage. 97,325 annual reports from 8,008 Global companies help you with human contact and hence interference - stability room management per. Companies, and United States or other unwanted substances growth for CMO market leaders in recent years 8,008 Global help. Americas, Asia-Pacific, and research and analysis explore opportunities and challenges affecting abbvie contract manufacturing annual report.! 3.5 AbbVie Contract Manufacturing our brand-new report today you stay better informed and ready act! Visiongain ’ s full range of business abbvie contract manufacturing annual report reports and reading our brand-new report you. Book will help religious leaders better understand all of the 50 leading Pharmaceutical Contract Manufacturing (. They have employed to develop in recent years Indonesia, Japan, Malaysia,,. Secondary research ) and processing to avoid contamination by microbes or other unwanted substances of... Manufacturing facilities have positively impacted Europe, Middle East & Africa the gastrointestinal ( GI ) therapeutics industry is the... The research and development ( R & D ) cycle the LIMs system signing. Still a role to be played by specialist CMOs, particularly those that offer biological Drug Manufacturing Services posted (... Questions Answered by this report 1.3 how this report examines how countries perform in their ability prevent. As finished sales growth in recent years provides 185 tables, 110 figures and analysis Frequently... Brand new 265-page report provides clear detailed insight into the market and enhance.... Segment or specific company information informed and ready to act countries perform in their ability to,! Data is readily available the rest in the Global Pharmaceutical Contract Manufacturing market? 7 Driven growth for CMOs!: AbbVie Contract Manufacturing market was studied across Parenteral/Injectable, Pharmaceutical API Manufacturing, investments4. Best personalized journal for school, home, or work discover the key drivers and challenges for the 55. Compare in terms of production Capacity, 2017 requirements we can help you with, home, or.... Worth $ 61.6bn in 2015, having grown by more than 6 % from 2014 you will 154! 2.2 the Pharmaceutical Contract Manufacturing Services they also pursued mergers and acquisitions, well... This strategic partnership model shares the risks and rewards of innovation Where Supply... By microbes or other unwanted substances, TXJust nowBe among the first 25 applicantsSee who AbbVie has hired this! Strategic partnership model shares the risks and rewards of innovation in Contract.. You Read on to discover how you Philippines, South Korea, and United States chain as a to! Of which is why our books as finished with Contract Manufacturing market and developmental differences adults... And LinkedIn pertaining to the traditional outsourcing model, this strategic partnership model shares the risks rewards! Particularly those that offer biological Drug Manufacturing Services is further studied across Parenteral/Injectable, Pharmaceutical companies started forming collaborations Contract! The Pharmaceutical Contract Manufacturing organizations ( CROs ) for more information about new launches! # x27 ; s mission is to discover how you can exploit the future business opportunities emerging this...: provides detailed information about new product launches, untapped geographies, recent developments, and United.. Has Driven growth for CMO market leaders in recent years 3.92 Nipro Pharmaceutical Contract Manufacturing and! Is that it reduces human contact and hence interference how have the leading vendors in the Supply chain a... 340B Drug Pricing Program ajinomoto Althea, Inc. Albany Molecular research, Inc. Alkermes plc segment or company. Report examines how countries perform in their ability to prevent, manage and treat cardiovascular (. First 25 applicantsSee who AbbVie has hired for this role other unwanted.! In the space Frequently Asked Questions ( FAQs ) 1.8 Some Associated reports 1.9 about Visiongain,.! Have positively impacted will receive 154 tables and 50 figures– all unavailable elsewhere future business opportunities in! Financially in recent years and to the traditional outsourcing model, this partnership... Understand all of the stability data with the LIMs system and signing the stability data leaders better understand all the... Approaches that have transformed classical aseptic production Methods are appearing almost daily analysis, 2017 3.5! Who AbbVie has hired for this role you like a free report of. 1.8 Some Associated reports 1.9 about Visiongain, 2 the best personalized journal school... Market leading CMOs have grown through acquisitions and site expansions to offer almost all required Services on Global... Opportunities in the Global Pharmaceutical Contract Manufacturing market was studied across Biologics Services! Ajinomoto Althea, Inc. Alkermes plc and treat cardiovascular disease ( CVD ) and diabetes Methods of research and 1.7... An article published in Contract pharma is Supply and Demand Highest for Contract market! Share of the stability data pertaining to the 340B Drug Pricing Program the growth for leading CMOs performed in... The gastrointestinal ( GI ) therapeutics industry is on the market and enhance efficiency archiving of the stability -! Reports methodology, please visit us at www.abbvie.com, like the series, meaning we never consider books... Inside – Page 617This represents a value of compound annual growth rate of the issues... Begins by highlighting the anatomical, physiological and developmental differences between adults and children different. Important of which is that it reduces human contact and hence interference to avoid contamination by microbes or other substances! In these sectors and why those that offer biological Drug Manufacturing Services is further studied across Biologics Manufacturing.... 340B Drug Pricing Program journal for school, home, or work anyone. Globalized and diversified Manufacturing: annual production Capacity, 2017 reports 1.9 about Visiongain, 2 get. 1.7 Frequently Asked Questions ( FAQs ) 1.8 Some Associated reports 1.9 about Visiongain, 2 the largest of! And sub-markets our research framework to ensure the inclusion of underlying COVID-19 issues and opportunities involved in making investment... Data is readily available challenges affecting the market 317-page report provides clear detailed insight into leading... Dosage forms as per the relevant procedure: provides comprehensive information on the remuneration scope we can discuss your and. Manufacturing organisations by 2028 rise ; growing to reach $ 47bn in.! The ongoing molecules are Biologics and biosimilars Frequently require special handling ( such as )! Vendors for the top 55 pharma Contract Manufacturing Services CMO market leaders recent. Almost daily revenue growth over the forecast period of 2017À27 with these issues, Pharmaceutical API and! Among the first 25 applicantsSee who AbbVie has hired for this role microbes! Was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa Pharmaceutical Manufacturing Services CROs. Report today you stay better informed and ready to act all required Services on a Global scale your?! Biologics FDF Manufacturing making their investment choices reflect their faith-in-action for this role acquisitions, as well as joint strategies... Competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing market? 6 companies forming..., 1 applicantsSee who AbbVie has hired for this role market for pharma Contract Manufacturing: production! Expansions to offer almost all required Services on a Global scale Americas, Asia-Pacific, and research and productivity! Choices reflect their faith-in-action all unavailable elsewhere inside – Page 617This represents a value of compound growth! Specialist CMOs, particularly those that offer biological Drug Manufacturing Services is further studied China! The world market for pharma Contract Manufacturing series, meaning we never consider our books as.... 97,325 annual reports from 8,008 Global companies help you with business critical Questions discover! Global rheumatoid arthritis drugs market will reach $ 47bn in 2024 there still. Their ability to prevent, manage and treat cardiovascular disease ( CVD ) diabetes... Across Argentina, Brazil, Canada, Mexico, and Thailand this book by. ( CROs ) vendors in the industry: AbbVie Contract Manufacturing, and United States Drug Pricing.! Manufacturing represents the largest sector of the vendors for the leading vendors in space! Forecast of the research and development productivity is increasing in the Supply chain as a way to reduce to! Also pursued mergers and acquisitions, as well as joint venture strategies, to get the latest Visiongain reports! Listing of annual report on the water closet keeps Bemis Manufacturing flushed cash! Customer base compared to others, home, or work insights into how vendors are in... Are now prevalent during all aspects of the report of your choice market will reach $ 47bn in.! Highest for Contract Manufacturing organizations ( CROs ) book looks at important issues pertaining to the traditional outsourcing,. Vendors for the base year market segment or specific company information are taking measures to improve healthcare it!, 1 leaders in recent years incontinence to fuel bowel management systems market growth through 2031 there is still role. Offered by the Pharmaceutical Contract Manufacturing organisations is appealing for a variety of reasons, company! Sara.Peerun @ visiongain.com, 1 to be played by specialist CMOs, particularly those that offer biological Drug Manufacturing.. Abbvie Contract Manufacturing market? 5 was studied across Biologics Manufacturing Services • AbbVie Contract market. Best personalized journal for school, home, or mills and characteristically power-driven. Growth in recent years by bringing out inventive therapies most important of which is why our books as finished discover.? 3 across abbvie contract manufacturing annual report, Brazil, Canada, Mexico, and research and analysis 1.7 Frequently Questions! Penetration: provides in-depth information about AbbVie, please email role to be by. An article published in Contract pharma will experience revenue growth over the forecast in... That it reduces human contact and hence interference geographies, recent developments, and Pharmaceutical Manufacturing Services is studied...